🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
As part of the ageing process muscles become weaker. One of the reasons for...
Status
Unknown
Location
University of East Anglia
Start Date
2024-02
Trial ID
NCT06262711
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
This study assesses efficacy of scalp block and Ultrasound guided transvers...
Status
Completed
Location
Yashoda Hospitals
Start Date
2017-07-15
Trial ID
NCT03667352
Treatments Being Tested
To investigate the effect of ultrasound-guided thoracic paravertebral nerve...
Status
Completed
Location
The First hosptial of Qinhuangdao
Start Date
2022-05-12
Trial ID
NCT05364216
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
This is a 24-week study investigating the safety and efficacy of several do...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-28
Trial ID
NCT00111800
Treatments Being Tested
The purpose of this study is to assess how well laroprovstat and ezetimibe ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2026-06-10
Trial ID
NCT07622433
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
The purpose of this study is to determine how the organism affects MMF (met...
Status
Completed
Location
Almirall Investigational Site #1
Start Date
2016-09
Trial ID
NCT02955693
Treatments Being Tested